Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Seligman

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cancer Chemotherapy Reports|May 11, 1975
Mutiple myeloma resistant to melphalan (NSC-8806) treated with cyclophosphamide (NSC-26271), prednisone (NSC-10023), and chloroquine (NSC-187208)R A Kyle, B R Seligman, H J Wallace, et al.
Annals of Ophthalmology|November 1, 1971
Secondary glaucoma in leukemiaA H Wolintz, J H Goldstein, B R Seligman, et al.
Cancer Treatment Reports|August 1, 1979
Multiple myeloma resistant to melphalan: treatment with cyclophosphamide, prednisone, and BCNUR A Kyle, S Gailani, B R Seligman, et al.
Cancer|August 15, 1980
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's diseaseM R Cooper, T F Pajak, N I Nissen, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cancer Chemotherapy Reports|May 11, 1975
Mutiple myeloma resistant to melphalan (NSC-8806) treated with cyclophosphamide (NSC-26271), prednisone (NSC-10023), and chloroquine (NSC-187208)R A Kyle, B R Seligman, H J Wallace, et al.
Annals of Ophthalmology|November 1, 1971
Secondary glaucoma in leukemiaA H Wolintz, J H Goldstein, B R Seligman, et al.
Cancer Treatment Reports|August 1, 1979
Multiple myeloma resistant to melphalan: treatment with cyclophosphamide, prednisone, and BCNUR A Kyle, S Gailani, B R Seligman, et al.
Cancer|August 15, 1980
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's diseaseM R Cooper, T F Pajak, N I Nissen, et al.
Pageof 2